Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection/Experiment 5/Signature 1
From BugSigDB
< Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection | Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut-brain-ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection/Experiment 5
Source: Figure 6C
Description: Post-intervention LEfSe analysis results at the genus level between the DHT-induced PCOS mouse model and the BL21 treatment group.
Abundance in Group 1: increased abundance in Bifidobacterium longum subsp. longum (BL21) group
| NCBI | Quality Control | Links |
|---|---|---|
| Ruminococcus | ||
| Rikenella | ||
| Lactobacillus | ||
| Lachnospiraceae NK4A136 groupLachnospiraceae NK4A136 group | ||
| Bifidobacterium | ||
| Bacteroides |
Revision editor(s): Victoria
